Streetbeat News

Analyst Ratings

DV

Stephens & Co analyst Nicholas Zangler initiated coverage on DoubleVerify Holdings Inc (DV) with an Overweight rating and a price target of $47. Zangler expects a revenue CAGR of +20% over the next several years due to growth in product launches, customer growth, and international expansion. The analyst estimates revenues of $563.0 million and adjusted EBITDA of $175.7 million in FY23 and $698.1 million and $222.5 million, respectively, in FY24.

Portfolio Pulse from Lekha Gupta

July 12, 2023 | 4:29 pm

CNK

B.Riley Securities analyst Eric Wold upgraded Cinemark Holdings Inc (NYSE:CNK) to Buy from Neutral, raising the price target to $23 from $20. Wold is confident about improved Q2 2023 results and the company's strong position in the global exhibition industry. He also raised the box office projection to $9.1 billion from $8.9 billion as YTD box office revenues exceed the initial forecast by ~4%. CNK shares are trading higher by 2.35% at $16.32.

Portfolio Pulse from Lekha Gupta

July 12, 2023 | 4:24 pm

EMN

Citigroup has raised its price target on Eastman Chemical's stock from $91 to $96, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 4:21 pm

CVNA

Carvana Co. (NYSE:CVNA) shares are trading higher after JMP Securities maintained an Outperform rating and raised its price target from $25 to $50. The stock has gained more than 50% in the last five days and more than 315% over the last three months. It has also received attention from retail investors on social media and short sellers, with 68.52% of available shares being sold short.

Portfolio Pulse from Erica Kollmann

July 12, 2023 | 4:19 pm

BIIB

Biogen Inc.'s (NASDAQ:BIIB) share price is currently at $280.50, after a 0.24% increase. However, the stock fell by 6.52% over the past month, but spiked by 30.88% in the past year. The company's P/E ratio of 13.03 is lower than the Biotechnology industry average of 49.03, which could indicate that the stock is undervalued or that shareholders do not expect the stock to perform better in the future.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 4:16 pm

BAC

DKNG

Bank of America Corp (BAC) Global Securities has upgraded DraftKings Inc (DKNG) from a Neutral to a Buy rating, increasing the price target from $26 to $32. The upgrade is based on DraftKings' product and revenue momentum, which are nearing a critical point that may lead to significant improvements in margins and profitability. BAC's new EBITDA estimate for DraftKings for 2025 is 17% above the consensus, with an additional 15%-25% upside potentially on the cards. DraftKings' market share in online sports betting has grown from 21% to 29% in the past year.

Portfolio Pulse from AJ Fabino

July 12, 2023 | 4:14 pm

RXRX

Berenberg analyst Gal Munda has reiterated a 'Buy' rating on Recursion Pharmaceuticals (NASDAQ:RXRX) and maintained a price target of $33.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 4:07 pm

SUI

Sun Communities' stock has been upgraded from Peer Perform to Outperform by Wolfe Research, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 4:04 pm

ZFOX

ZeroFox Holdings (NASDAQ:ZFOX) has received 4 analyst ratings in the last quarter, with 1 being bullish and 3 somewhat bullish. The average 12-month price target for the stock is $3.25, a 35.0% decrease from the previous average price target of $5.00.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 4:01 pm

EMR

Over the past 3 months, 11 analysts have published their opinion on Emerson Electric (NYSE:EMR) stock. The average price target is $103.0, implying an upside from the current price of $92.31. The current average has increased by 2.61% from the previous average price target of $100.38.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 4:01 pm